Review on anti-alzheimer drug development: approaches, challenges and perspectives
AE Abdallah - RSC advances, 2024 - pubs.rsc.org
Alzheimer is an irreversible progressive neurodegenerative disease that causes failure of
cerebral neurons and disability of the affected person to practice normal daily life activities …
cerebral neurons and disability of the affected person to practice normal daily life activities …
Natural and Synthetic Phosphodiesterase Inhibitors in 2023: an Update on the Impact on Neurological and Psychiatric Conditions
G Ribaudo, A Gianoncelli - Mini Reviews in Medicinal …, 2024 - ingentaconnect.com
This Perspective provides an updated overview on the involvement of phosphodiesterase
(PDE) isoforms and of the corresponding inhibitors in neurological disorders, including …
(PDE) isoforms and of the corresponding inhibitors in neurological disorders, including …
Insights in ethnopharmacology: 2022
In the third decade of the 21st century, scientists continue to achieve tremendous
accomplishments in the field of ethnopharmacology/medicinal plant research (Kim et al.) …
accomplishments in the field of ethnopharmacology/medicinal plant research (Kim et al.) …
Synthesis and pharmacological activity of vinpocetine derivatives
ZC Dong, Y Shi, LJ Liu, TT Feng, Y Zhou, BW Pan - RSC advances, 2024 - pubs.rsc.org
Vinpocetine and its derivatives were extensively employed in the treatment of ischemic
stroke, serving as effective cerebrovascular vasodilators. They could also be utilized for …
stroke, serving as effective cerebrovascular vasodilators. They could also be utilized for …